Webinar Internasional : Pharmacy Challenge in Preventing and Managing Covid-19 Pandemic

Deskripsi Event :

The Covid-19 pandemic that is currently happening has indeed had many impacts in the society, such as public health and socioeconomic. The pandemic has upended health systems all over the world and clinical pharmacy has not been spared from this disruption. By the first of 2020 until 23th November 2021, more than four million Indonesian had received diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Although a substantial proportion of these infections remained asymptomatic, complications of coronavirus disease 2019 (Covid-19) had led to approximately 143.753 deaths in Indonesia. During past year, government has devoted to the development of vaccines to prevent Covid-19 and to reduce the morbidity and mortality among people who are infected. Developing of appropriate treatment is equally important to prevent the progression of Covid-19 infection and treat its complication. In this issue, many research provoked that monoclonal antibodies (mAb) has potential agent to developed as Covid-19 therapy. The mAb serve as an antiviral agent to reduce the viral load in the nasopharynx. The effects of mAb and other drugs on viral load may prove to be an important criterion for the development of agents to treat early Covid-19. Such monoclonal antibodies may also be successful in preventing SARS-CoV-2 infection as an alternative to vaccination for people who cannot take a vaccine or need more immediate prophylaxis either before or after exposure. In addition, during Covid-19 recovery, adjunctive therapies are frequently used in the prevention and/or treatment of COVID-19 or its complications. Some of these agents are being studied in clinical trials. Some clinicians advocate for the use of vitamin and mineral supplements to treat respiratory viral infections. Ongoing studies are evaluating the use of vitamin and mineral supplements for both the treatment and prevention of SARS-CoV-2 infection. On the other hand, some countries, like a China and India use different traditional medicinal plants, which are vast reservoir of bioactive compounds with broad therapeutic and immunomodulatory properties to combat with Covid-19. Along with pharmacological properties and easily availability, safety paradigm of ethnomedicinal plants makes them highly preferable immediate remedy to enhance immunity and compete with Covid-19. Use of traditional Indian spices has been also realized as effective and safer strategy in order to boost immunity and deal with highly terrible current Covid-19 situation. Hence, there is need to boost the efficacy of the traditionally used plant based immunomodulators against Covid- 19 pandemic incorporating modern biotechnological and pharmacological tools so as to enhance bioavailability and practical applicability. Politeknik Katolik Mangunwijaya and STIKES IKIFA are educational institutions that have remarkable effort to create assistant pharmacy who has great competency by updating our pharmaceutical knowledge. We are improving our capability by making collaboration with several great institutions, ie Mahsa University and Surabaya University. In this great moment, we are willing to follow up the collaboration by organizing the seminar “Pharmacy Challenge in Preventing and Managing Covid-19 Pandemic”. Additionally, we hope that this seminar can equip our student more knowledgable about updating Covid-19 treatment

Partisipan yang dituju :

  • Lecturers
  • Students

Moderator :

  • apt., Paulina Maya Octasari, M.Sc.
  • Ika Agustina,
    S.Si., M.Farm.

Pembicara :

  • Dr. Vetriselvan Subramaniyan (MAHSA University)
  • Dr. apt. Oeke Yunita, S.Si., M.Si. (Universitas Surabaya)
  • Apt. Septiana Laksmi R., M.Sc.

Detail :

Tipe Acara





18 Desember 2021



07.30 -13.15



Ruang Zoom

Link Pendaftaran


Klik di sini

Biaya/HTM :

Contact Person :

  • Amel (08139 0813991)
  • Bayu (08561488224)